News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,404 Results
Type
Article (49660)
Company Profile (278)
Press Release (683466)
Section
Business (212254)
Career Advice (2098)
Deals (36531)
Drug Delivery (103)
Drug Development (83595)
Employer Resources (173)
FDA (16953)
Job Trends (15705)
News (359171)
Policy (34658)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2774)
Accelerated approval (2)
Adcomms (23)
Allergies (83)
Alliances (51541)
ALS (85)
Alzheimer's disease (1404)
Antibody-drug conjugate (ADC) (112)
Approvals (16951)
Artificial intelligence (247)
Autoimmune disease (14)
Automation (14)
Bankruptcy (373)
Best Places to Work (12096)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (191)
Bladder cancer (58)
Brain cancer (25)
Breast cancer (257)
Cancer (2013)
Cardiovascular disease (157)
Career advice (1758)
Career pathing (30)
CAR-T (142)
Cell therapy (398)
Cervical cancer (19)
Clinical research (67574)
Collaboration (783)
Compensation (449)
Complete response letters (20)
COVID-19 (2708)
CRISPR (35)
C-suite (212)
Cystic fibrosis (99)
Data (1919)
Decentralized trials (2)
Denatured (26)
Depression (43)
Diabetes (248)
Diagnostics (6540)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (110)
Drug pricing (102)
Drug shortages (28)
Duchenne muscular dystrophy (86)
Earnings (88263)
Editorial (34)
Employer branding (21)
Employer resources (147)
Events (116581)
Executive appointments (642)
FDA (18081)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (702)
Gene editing (98)
Generative AI (24)
Gene therapy (277)
GLP-1 (729)
Government (4648)
Grass and pollen (4)
Guidances (48)
Healthcare (19890)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (105)
Indications (27)
Infectious disease (2842)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (83)
Interviews (319)
IPO (16852)
IRA (41)
Job creations (4043)
Job search strategy (1501)
Kidney cancer (9)
Labor market (34)
Layoffs (466)
Leadership (16)
Legal (8454)
Liver cancer (73)
Lung cancer (296)
Lymphoma (130)
Machine learning (2)
Management (58)
Manufacturing (270)
MASH (62)
Medical device (14317)
Medtech (14322)
Mergers & acquisitions (20148)
Metabolic disorders (655)
Multiple sclerosis (69)
NASH (16)
Neurodegenerative disease (86)
Neuropsychiatric disorders (28)
Neuroscience (1889)
NextGen: Class of 2025 (6910)
Non-profit (4736)
Northern California (2403)
Now hiring (37)
Obesity (359)
Opinion (215)
Ovarian cancer (72)
Pain (80)
Pancreatic cancer (77)
Parkinson's disease (135)
Partnered (18)
Patents (202)
Patient recruitment (95)
Peanut (48)
People (59902)
Pharmaceutical (68)
Pharmacy benefit managers (19)
Phase I (21019)
Phase II (29691)
Phase III (22192)
Pipeline (969)
Podcasts (57)
Policy (110)
Postmarket research (2741)
Preclinical (8934)
Press Release (67)
Prostate cancer (94)
Psychedelics (32)
Radiopharmaceuticals (253)
Rare diseases (361)
Real estate (6297)
Recruiting (65)
Regulatory (23536)
Reports (46)
Research institute (2478)
Resumes & cover letters (359)
Rett syndrome (3)
RNA editing (2)
RSV (39)
Schizophrenia (68)
Series A (121)
Series B (79)
Service/supplier (13)
Sickle cell disease (50)
Southern California (2082)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3826)
State (2)
Stomach cancer (13)
Supply chain (62)
The Weekly (28)
United States (21331)
Vaccines (691)
Venture capitalists (38)
Webinars (12)
Weight loss (251)
Women's health (36)
Worklife (15)
Date
Last 7 days (575)
Last 30 days (2585)
Last 365 days (34298)
2025 (7839)
2024 (36109)
2023 (41146)
2022 (52382)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (793)
Alabama (50)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (40853)
Australia (6734)
California (5499)
Canada (1866)
China (482)
Colorado (255)
Connecticut (272)
Delaware (126)
Europe (88426)
Florida (816)
Georgia (198)
Idaho (61)
Illinois (528)
India (23)
Indiana (295)
Iowa (9)
Japan (139)
Kansas (103)
Kentucky (24)
Louisiana (8)
Maine (60)
Maryland (863)
Massachusetts (4180)
Michigan (214)
Minnesota (381)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (58)
New Hampshire (67)
New Jersey (1577)
New Mexico (29)
New York (1581)
North Carolina (974)
North Dakota (7)
Northern California (2403)
Ohio (192)
Oklahoma (14)
Oregon (34)
Pennsylvania (1246)
Puerto Rico (9)
Rhode Island (28)
South America (1183)
South Carolina (19)
South Dakota (1)
Southern California (2082)
Tennessee (94)
Texas (824)
Utah (167)
Virginia (132)
Washington D.C. (61)
Washington State (523)
West Virginia (3)
Wisconsin (49)
733,404 Results for "microbot medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Microbot Medical Closes $8.6 Million Registered Direct Offering
January 10, 2025
·
5 min read
Press Releases
Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
March 4, 2025
·
4 min read
Press Releases
Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
February 10, 2025
·
5 min read
Press Releases
Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors
January 13, 2025
·
4 min read
Press Releases
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®
December 30, 2024
·
4 min read
Press Releases
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
December 11, 2024
·
3 min read
FDA
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
Microbot Medical Inc. announces that it has received the U.S. Food and Drug Administration’s approval to proceed with its pivotal human clinical trial as part of its Investigational Device Exemption application for its LIBERTY® Endovascular Robotic Surgical System.
June 3, 2024
·
3 min read
Press Releases
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
December 10, 2024
·
3 min read
Business
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
Microbot Medical Inc., developer of the innovative LIBERTY® Endovascular Robotic Surgical System, reports that the first phase of the previously announced collaboration with Corewell Health has been completed, which demonstrated the LIBERTY® System’s technical capabilities and outlines potential future applications in a range of endovascular interventions.
April 29, 2024
·
3 min read
Genetown
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Microbot Medical Inc. announced that it has entered into definitive agreements for the purchase and sale of 1,566,669 shares of the Company’s common stock at a purchase price of $1.50 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules.
June 3, 2024
·
5 min read
1 of 73,341
Next
